BGNE
Income statement / Annual
Last year (2023), BeiGene, Ltd.'s total revenue was $2.46 B,
an increase of 73.65% from the previous year.
In 2023, BeiGene, Ltd.'s net income was -$881.71 M.
See BeiGene, Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.46 B
|
$1.42 B
|
$1.18 B
|
$308.87 M
|
$428.21 M
|
$198.22 M
|
$238.39 M
|
$1.07 M
|
$8.82 M
|
$13.04 M
|
| Cost of Revenue |
$379.92 M |
$1.93 B |
$1.62 B |
$1.37 B |
$998.53 M |
$707.71 M |
$273.99 M |
$98.03 M |
$58.25 M |
$21.86 M |
| Gross Profit |
$2.08 B |
-$511.06 M |
-$447.86 M |
-$1.06 B |
-$570.32 M |
-$509.49 M |
-$35.61 M |
-$96.96 M |
-$49.43 M |
-$8.83 M |
| Gross Profit Ratio |
0.85 |
-0.36 |
-0.38 |
-3.42 |
-1.33 |
-2.57 |
-0.15 |
-90.62 |
-5.61 |
-0.68 |
| Research and Development
Expenses |
$1.78 B
|
$1.64 B
|
$1.46 B
|
$1.29 B
|
$927.34 M
|
$679.01 M
|
$269.02 M
|
$98.03 M
|
$58.25 B
|
$21.86 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$195.39 M
|
$62.60 M
|
$20.10 M
|
$7.31 M
|
$6.93 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.50 B
|
$1.28 B
|
$990.12 M
|
$600.18 M
|
$388.25 M
|
$195.39 M
|
$62.60 M
|
$20.10 M
|
$7.31 M
|
$6.93 M
|
| Other Expenses |
$3.50 M |
-$1.64 B |
$750,000.00 |
$846,000.00 |
$1.33 M |
$894,000.00 |
$250,000.00 |
-$2.49 M |
-$916,000.00 |
$600,000.00 |
| Operating Expenses |
$3.29 B |
$1.28 B |
$990.87 M |
$601.02 M |
$389.58 M |
$196.28 M |
$62.85 M |
$20.10 M |
$7.31 M |
$6.93 M |
| Cost And Expenses |
$3.67 B |
$3.21 B |
$2.62 B |
$1.97 B |
$1.39 B |
$903.99 M |
$336.84 M |
$118.13 M |
$65.56 M |
$28.79 M |
| Interest Income |
$0.00 |
$74.18 M |
$13.51 M |
$2.00 M |
$9.13 M |
$0.00 |
$0.00 |
$0.00 |
$1.79 M |
$40,000.00 |
| Interest Expense |
$0.00 |
$52.48 M |
$0.00 |
$338,000.00 |
$9.13 M |
$13.95 M |
$0.00 |
$383,000.00 |
$1.23 M |
$3.55 M |
| Depreciation &
Amortization |
$87.68 M
|
$66.28 M
|
$46.46 M
|
$31.79 M
|
$18.62 M
|
$9.89 M
|
$4.59 M
|
$1.91 M
|
$1.55 M
|
$1.56 M
|
| EBITDA |
-$1.12 B
|
-$1.73 B
|
-$1.39 B
|
-$1.63 B
|
-$941.27 M
|
-$695.38 M
|
-$93.70 M
|
-$115.15 M
|
-$55.20 M
|
-$14.20 M
|
| EBITDA Ratio |
-0.46 |
-1.26 |
-1.22 |
-5.36 |
-2.24 |
-3.43 |
-0.36 |
-109.58 |
-6.16 |
-1.01 |
| Operating Income Ratio
|
-0.49
|
-1.26
|
-1.22
|
-5.37
|
-2.24
|
-3.56
|
-0.41
|
-109.4
|
-6.44
|
-1.21
|
| Total Other
Income/Expenses Net |
$381.90 M
|
-$171.37 M
|
$147,000.00
|
$39.49 M
|
$16.31 M
|
$15.94 M
|
$7.39 M
|
-$2.10 M
|
-$357,000.00
|
-$2.79 M
|
| Income Before Tax |
-$825.84 M |
-$1.96 B |
-$1.44 B |
-$1.62 B |
-$943.59 M |
-$689.83 M |
-$91.06 M |
-$119.16 M |
-$57.10 M |
-$18.55 M |
| Income Before Tax Ratio
|
-0.34
|
-1.38
|
-1.22
|
-5.24
|
-2.2
|
-3.48
|
-0.38
|
-111.37
|
-6.48
|
-1.42
|
| Income Tax Expense |
$55.87 M |
$42.78 M |
-$25.23 M |
-$17.67 M |
$6.99 M |
-$15.80 M |
$2.24 M |
$54,000.00 |
$872,000.00 |
$763,000.00 |
| Net Income |
-$881.71 M |
-$2.00 B |
-$1.41 B |
-$1.60 B |
-$950.58 M |
-$673.77 M |
-$93.11 M |
-$119.22 M |
-$57.10 M |
-$18.28 M |
| Net Income Ratio |
-0.36 |
-1.42 |
-1.2 |
-5.18 |
-2.22 |
-3.4 |
-0.39 |
-111.42 |
-6.48 |
-1.4 |
| EPS |
-8.45 |
-19.43 |
-15.23 |
-19.17 |
-15.83 |
-12.15 |
-2.04 |
-3 |
-1.81 |
-0.35 |
| EPS Diluted |
-8.45 |
-19.43 |
-15.23 |
-19.17 |
-15.83 |
-12.15 |
-2.04 |
-3 |
-1.81 |
-0.35 |
| Weighted Average Shares
Out |
$104.39 M
|
$103.13 M
|
$92.79 M
|
$83.47 M
|
$60.05 M
|
$55.44 M
|
$45.54 M
|
$39.68 M
|
$31.52 M
|
$52.66 M
|
| Weighted Average Shares
Out Diluted |
$104.39 M
|
$103.13 M
|
$92.79 M
|
$83.47 M
|
$60.05 M
|
$55.44 M
|
$45.54 M
|
$39.68 M
|
$31.52 M
|
$52.66 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
